CellVoyant logo

CellVoyant

We see the future in cells

16 employees · est. 2021 · Bristol, United Kingdom

VS
DeepLife logo

DeepLife

AI for digital twin of cells

31 employees · est. 2019 · Paris, France

DeepLife is the older company (2021 vs 2019).

Side-by-Side Comparison

CellVoyant DeepLife
Founded
2021 2019 older
Headquarters
Bristol, United Kingdom Paris, France
Employees
16 31
Industry
AI, Biotechnology AI, Biotechnology, Machine Learning
Funding Stage
Unknown Series A
Total Funding
$7.60M $16.00M
Funding Rounds
2 3
Services
FateView™ - AI-powered cell state prediction, FateDrive™ - AI-driven process optimisation Development of digital twins for cells, Drug discovery solutions, Multi-omics data analysis, AI and systems engineering for biotech applications
Target Customers
Biotech Companies, Pharmaceutical Researchers, Cell Therapy Developers, Stem Cell Scientists Pharmaceutical companies, Biotech researchers, Health institutions, Investors interested in biotech innovations, Scientific collaborators
Taxonomy
AI-first Biotechnology, Stem Cell Therapy, Live Cell Imaging, Cell Manufacturing, Machine Learning, Cell Biology, Computer Vision, Venture Capital, Biotech Startup, Research And Development, Deep Learning, Medical Innovation, Science Industrialization Digital Twin, Cell Engineering, SaaS Platform, Multi-omics Sequencing, Deep Learning Algorithms, In Silico Simulations, Pharmaceutical Target Identification, Molecular Triggers, System Biology, Translational Research, Biotech Collaboration, Cell Atlases, Deep Learning-Based Tools, Drug Discovery
Website
cellvoyant.com deeplife.co
CellVoyant logo

About CellVoyant

CellVoyant, founded in 2021 and headquartered in the United Kingdom, operates at the forefront of AI and Biotechnology, living up to its slogan, “We see the future in cells.” The company, born from research at the University of Bristol's Carazo Salas lab, leverages AI-first live cell imaging technol...

DeepLife logo

About DeepLife

DeepLife, an innovative startup founded in 2019, is making significant strides in biotechnology by developing the first SaaS platform for creating a Digital Twin of cells. They leverage advanced AI and machine learning to transform cell engineering by simulating cell behavior in silico, aiming to co...

We will tell you when either one moves

BounceWatch watches CellVoyant and DeepLife for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at CellVoyant and DeepLife — by email.

Frequently Asked Questions

CellVoyant — We see the future in cells. DeepLife — AI for digital twin of cells. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
CellVoyant has raised $7.60M while DeepLife has raised $16.00M.
CellVoyant and DeepLife operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare CellVoyant with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at CellVoyant on 12 Sep 2024, and DeepLife on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy